View in EDS HTML Full Text PDF Full Text

Safety and immunogenicity of an mRNA-based RSV vaccine in seropositive children aged 12-59 months.

Saved in:
Bibliographic Details
Title: Safety and immunogenicity of an mRNA-based RSV vaccine in seropositive children aged 12-59 months.
Authors: Schnyder Ghamloush S; Moderna, Inc., Cambridge, MA, USA., Fanning S; The Alliance for Multispecialty Research, LLC, Knoxville, TN, USA., Essink B; Velocity Clinical Research, Omaha, NE, USA., Eder F; Velocity Clinical Research, Omaha, NE, USA., Snape MD; Moderna Biotech Manufacturing UK, Harwell Science and Innovation Centre, Didcot, UK., Stoszek SK; Moderna, Inc., Cambridge, MA, USA., Guo R; Moderna, Inc., Cambridge, MA, USA., Dhar R; Moderna, Inc., Cambridge, MA, USA., Righi V; Moderna, Inc., Cambridge, MA, USA., Morsy L; Moderna, Inc., Cambridge, MA, USA., Kapoor A; Moderna, Inc., Cambridge, MA, USA., El Asmar L; Moderna, Inc., Cambridge, MA, USA., Shaw CA; Moderna, Inc., Cambridge, MA, USA.
Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2025 Dec; Vol. 21 (1), pp. 2557676. Date of Electronic Publication: 2025 Sep 15.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40953212
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and immunogenicity of an mRNA-based RSV vaccine in seropositive children aged 12-59 months.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Schnyder+Ghamloush+S%22">Schnyder Ghamloush S</searchLink>; Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Fanning+S%22">Fanning S</searchLink>; The Alliance for Multispecialty Research, LLC, Knoxville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Essink+B%22">Essink B</searchLink>; Velocity Clinical Research, Omaha, NE, USA.<br /><searchLink fieldCode="AU" term="%22Eder+F%22">Eder F</searchLink>; Velocity Clinical Research, Omaha, NE, USA.<br /><searchLink fieldCode="AU" term="%22Snape+MD%22">Snape MD</searchLink>; Moderna Biotech Manufacturing UK, Harwell Science and Innovation Centre, Didcot, UK.<br /><searchLink fieldCode="AU" term="%22Stoszek+SK%22">Stoszek SK</searchLink>; Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Guo+R%22">Guo R</searchLink>; Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Dhar+R%22">Dhar R</searchLink>; Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Righi+V%22">Righi V</searchLink>; Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Morsy+L%22">Morsy L</searchLink>; Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kapoor+A%22">Kapoor A</searchLink>; Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22El+Asmar+L%22">El Asmar L</searchLink>; Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shaw+CA%22">Shaw CA</searchLink>; Moderna, Inc., Cambridge, MA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101572652%22">Human vaccines & immunotherapeutics</searchLink> [Hum Vaccin Immunother] 2025 Dec; Vol. 21 (1), pp. 2557676. <i>Date of Electronic Publication: </i>2025 Sep 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101572652 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2164-554X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221645515%22">21645515 </searchLink><i>NLM ISO Abbreviation: </i>Hum Vaccin Immunother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40953212
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/21645515.2025.2557676
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2557676
    Titles:
      – TitleFull: Safety and immunogenicity of an mRNA-based RSV vaccine in seropositive children aged 12-59 months.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schnyder Ghamloush S
      – PersonEntity:
          Name:
            NameFull: Fanning S
      – PersonEntity:
          Name:
            NameFull: Essink B
      – PersonEntity:
          Name:
            NameFull: Eder F
      – PersonEntity:
          Name:
            NameFull: Snape MD
      – PersonEntity:
          Name:
            NameFull: Stoszek SK
      – PersonEntity:
          Name:
            NameFull: Guo R
      – PersonEntity:
          Name:
            NameFull: Dhar R
      – PersonEntity:
          Name:
            NameFull: Righi V
      – PersonEntity:
          Name:
            NameFull: Morsy L
      – PersonEntity:
          Name:
            NameFull: Kapoor A
      – PersonEntity:
          Name:
            NameFull: El Asmar L
      – PersonEntity:
          Name:
            NameFull: Shaw CA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2164-554X
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Human vaccines & immunotherapeutics
              Type: main
ResultId 1